CML (CHRONIC MYELOGENOUS LEUKEMIA)
Clinical trials for CML (CHRONIC MYELOGENOUS LEUKEMIA) explained in plain language.
Never miss a new study
Get alerted when new CML (CHRONIC MYELOGENOUS LEUKEMIA) trials appear
Sign up with your email to follow new studies for CML (CHRONIC MYELOGENOUS LEUKEMIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cell shot free CML patients from daily pills?
Disease control Recruiting nowThis early-stage trial tests a cell therapy called vididencel in 24 adults with chronic myeloid leukemia (CML) who still have traces of cancer despite taking standard medication. The goal is to see if adding vididencel to their current treatment is safe and might eventually allow…
Matched conditions: CML (CHRONIC MYELOGENOUS LEUKEMIA)
Phase: PHASE1 • Sponsor: Mendus • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktails aim to tame transplant complications in blood cancer patients
Disease control Recruiting nowThis study tests whether new drug combinations can better prevent graft-versus-host disease (GVHD) in people with blood cancers who receive a stem cell transplant from a mismatched unrelated donor. About 358 participants will get either the standard GVHD prevention or one of two …
Matched conditions: CML (CHRONIC MYELOGENOUS LEUKEMIA)
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC